Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 76.07% vs 8.74% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 28.44% vs 26.23% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 840.00% vs 0.00% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 66.22% vs 28.33% in Mar 2025
Compare Balance Sheet Results of Oxygenta Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
36.98
3.57
33.41
935.85%
Share Warrants & Outstandings
Total Reserve
-79.67
197.63
-277.30
-140.31%
Shareholder's Funds
-42.69
201.21
-243.90
-121.22%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
75.29
0.00
75.29
0.00%
Secured Loans
23.17
0.00
23.17
0.00%
Unsecured Loans
52.11
0.00
52.11
0.00%
Deferred Tax Assets / Liabilities
-17.41
2.55
-19.96
-782.75%
Other Long Term Liabilities
0.00
0.34
-0.34
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.98
0.41
0.57
139.02%
Total Non-Current Liabilities
58.86
3.30
55.56
1,683.64%
Current Liabilities
Trade Payables
48.77
6.62
42.15
636.71%
Other Current Liabilities
2.79
13.08
-10.29
-78.67%
Short Term Borrowings
34.28
3.56
30.72
862.92%
Short Term Provisions
0.26
1.70
-1.44
-84.71%
Total Current Liabilities
86.10
24.96
61.14
244.95%
Total Liabilities
102.27
229.46
-127.19
-55.43%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
74.58
50.53
24.05
47.60%
Less: Accumulated Depreciation
26.98
28.72
-1.74
-6.06%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
47.60
21.81
25.79
118.25%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
2.48
-2.48
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.47
25.72
-25.25
-98.17%
Long Term Loans & Advances
1.00
2.41
-1.41
-58.51%
Other Non Current Assets
1.77
0.49
1.28
261.22%
Total Non-Current Assets
50.84
52.92
-2.08
-3.93%
Current Assets Loans & Advances
Current Investments
0.00
27.54
-27.54
-100.00%
Inventories
29.42
9.87
19.55
198.07%
Sundry Debtors
10.03
33.64
-23.61
-70.18%
Cash and Bank
2.15
79.87
-77.72
-97.31%
Other Current Assets
7.47
6.81
0.66
9.69%
Short Term Loans and Advances
2.36
18.81
-16.45
-87.45%
Total Current Assets
51.43
176.55
-125.12
-70.87%
Net Current Assets (Including Current Investments)
-34.67
151.59
-186.26
-122.87%
Total Current Assets Excluding Current Investments
51.43
149.00
-97.57
-65.48%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
102.27
229.46
-127.19
-55.43%
Contingent Liabilities
0.16
0.00
0.16
0.00%
Total Debt
109.57
3.56
106.01
2,977.81%
Book Value per share (adjusted)
-11.54
563.19
-574.73
-102.05%
Annual - Borrowings
Borrowings 109.57 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 76.07% vs 8.74% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 47.60 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 28.44% vs 26.23% in Mar 2025
Annual - Investments
Investments 0.47 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 840.00% vs 0.00% in Mar 2025
Annual - Current Assets
Current Assets 51.43 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 66.22% vs 28.33% in Mar 2025
